How big is Dyadic International, Inc.?

As of Jun 18, Dyadic International, Inc. has a market capitalization of 38.96 million and reported net sales of 3.56 million with a net profit of -5.83 million over the latest four quarters. Shareholder's funds are at 2.47 million and total assets at 9.93 million.

As of Jun 18, Dyadic International, Inc. has a market capitalization of 38.96 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of Net Sales for the latest four quarters is 3.56 million, while the sum of Net Profit for the same period is -5.83 million.<BR><BR>As of Dec 24, the reporting period shows Shareholder's Funds at 2.47 million and Total Assets at 9.93 million.

What does Dyadic International, Inc. do?

Dyadic International, Inc. is a biotechnology company that develops and licenses its C1 platform for pharmaceutical applications in human and animal markets. As of March 2025, it has a market cap of $38.96 million, with net sales of $0 million and a net loss of $2 million.

Overview:<BR>Dyadic International, Inc. is a global biotechnology company focused on developing and licensing the C1 platform for pharmaceutical applications in both human and animal markets, operating within the Pharmaceuticals & Biotechnology industry and categorized as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 0 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -2 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 38.96 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -2.30 <BR>Return on Equity: -582.71% <BR>Price to Book: 38.96<BR><BR>Contact Details:<BR>Address: 140 Intracoastal Pointe Dr Ste 404, JUPITER FL : 33477-5094 <BR>Tel: 1 561 7438333 <BR>Fax: 1 561 7438343 <BR>Website: http://www.dyadic.com/

Should I buy, sell or hold Dyadic International, Inc.?

Who are in the management team of Dyadic International, Inc.?

As of March 2022, the management team of Dyadic International, Inc. includes Michael Tarnok (Independent Chairman), Mark Emalfarb (CEO), and several independent directors: Arindam Bose, Barry Buckland, Seth Herbst, Jack Kaye, and Patrick Lucy.

As of March 2022, the management team of Dyadic International, Inc. includes the following individuals:<BR><BR>- Mr. Michael Tarnok, Independent Chairman of the Board<BR>- Mr. Mark Emalfarb, President, Chief Executive Officer, Director<BR>- Dr. Arindam Bose, Independent Director<BR>- Dr. Barry Buckland, Independent Director<BR>- Dr. Seth Herbst, Independent Director<BR>- Mr. Jack Kaye, Independent Director<BR>- Mr. Patrick Lucy, Independent Director<BR><BR>This team comprises a mix of executive leadership and independent directors.

Is Dyadic International, Inc. overvalued or undervalued?

As of March 27, 2019, Dyadic International, Inc. is considered a risky investment due to its high Price to Book Value of 41.92, negative earnings ratios, and a significant decline in stock performance, with a year-to-date return of -43.91% and a five-year decline of -87.82%.

As of 27 March 2019, the valuation grade for Dyadic International, Inc. moved from does not qualify to risky, indicating a significant downgrade in its investment appeal. The company appears to be overvalued, particularly given its high Price to Book Value of 41.92 and negative EV to EBIT and EV to EBITDA ratios of -6.89, which suggest that the company is not generating positive earnings before interest and taxes or earnings before interest, taxes, depreciation, and amortization. Additionally, the negative ROE of -582.71% further underscores the company's financial struggles.<BR><BR>In comparison to its peers, Dyadic's P/E ratio is notably absent due to its loss-making status, while Nutex Health, Inc. presents a very attractive P/E of 3.08, highlighting a stark contrast in valuation metrics. Other risky peers like Personalis, Inc. and Sonida Senior Living, Inc. also show negative valuations, but with less extreme ratios than Dyadic. The stock's performance has been disappointing, with a year-to-date return of -43.91%, significantly underperforming the S&P 500's 12.22% return, and a staggering decline of -87.82% over the past five years, further reinforcing the notion that the stock is overvalued in its current state.

Is Dyadic International, Inc. technically bullish or bearish?

As of September 2, 2025, Dyadic International, Inc. shows a mildly bearish trend, with daily moving averages indicating bearishness, while weekly indicators suggest mild bullishness, and the stock has underperformed the S&P 500 with a year-to-date return of -43.91%.

As of 2 September 2025, the technical trend for Dyadic International, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by the daily moving averages indicating a bearish trend, while the weekly MACD and KST show mildly bullish signals. The Bollinger Bands are bullish on the weekly timeframe but mildly bearish on the monthly. The stock has underperformed against the S&P 500 across multiple periods, with a year-to-date return of -43.91% compared to the S&P 500's 12.22%.